Oncimmune Holdings signs agreements with Roche and Cedars-Sinai
LONDON: Oncimmune Holdings plc has signed two separate agreements with Roche Pharmaceuticals and Cedars-Sinai Medical Center, in each case to use the company’s newly developed...
Oncimmune signs agreement with Cedars-Sinai to profile immune response to COVID-19
LONDON: Oncimmune Holdings plc has signed a commercial agreement with Cedars-Sinai, California, USA, to provide antibody profiling in COVID-19 samples as biomarkers for this disease,...
Oncimmune announces UK Government funding for tool for use in COVID-19
LONDON: Oncimmune Holdings announced the award of funding from the ‘UK Research and Innovation (UKRI) Ideas to Address COVID-19’ programme, to support a joint collaboration...